Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
40%
OVERLAP
BY WEIGHT
19
# OF OVERLAPPING
HOLDINGS
FMED
62
HOLDINGS
35%
ALSO IN GDOC
GDOC
39
HOLDINGS
51%
ALSO IN FMED
SECTOR DRIFT (FMED minus GDOC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FMED |
Weight in GDOC |
Overlap | |
|---|---|---|---|---|
 |
BOSTON SCIENTIFIC CORP | 7.9% | 9.0% | 7.9% |
|
INSULET CORP | 6.0% | 6.1% | 6.0% |
|
INTUITIVE SURGICAL INC | 4.0% | 5.2% | 4.0% |
|
ALNYLAM PHARMACEUTICALS INC | 5.2% | 3.2% | 3.2% |
 |
ARGENX SE ADR | 4.3% | 3.0% | 3.0% |
FMED Overweight Relative to GDOC
|
UCB SA | 3.4% |
|
PENUMBRA, INC. | 3.3% |
|
STRYKER CORP | 2.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 2.6% |
|
EDWARDS LIFESCIENCES CORP | 2.5% |
|
REGENERON PHARMACEUTICALS | 2.4% |
|
EXACT SCIENCES CORP | 2.4% |
|
DEXCOM INC | 2.2% |
|
ALNYLAM PHARMACEUTICALS INC | 2.0% |
|
MASIMO CORPORATION | 1.9% |
FMED Underweight Relative to GDOC
|
ELI LILLY & CO | -6.5% |
|
ABBVIE INC | -6.3% |
|
ABBOTT LABORATORIES | -5.1% |
 |
ASTRAZENECA PLC | -4.4% |
|
MERCK & CO. INC. | -3.6% |
|
COOPER COS INC/THE | -3.0% |
 |
HOYA CORP | -3.0% |
|
NEUROCRINE BIOSCIENCES INC | -2.7% |
|
BIOMARIN PHARMACEUTICAL INC | -2.7% |
 |
CSL LIMITED | -2.6% |